- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04725981
Vaginal Stump Infection After Laparoscopic Hysterectomy (CoToIn)
Vaginal Stump Infection After Total Laparoscopic or Robot-assisted Hysterectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kanton Zurich
-
Schlieren, Kanton Zurich, Switzerland, 8952
- Spital Limmattal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient > = 18 years old
- Indication for total laparoscopic or robot-assisted hysterectomy
- Benign uterine disease
- Signed informed consent for study participation
Exclusion Criteria:
- Patient with malignant gynecological diseases
Combination with other abdominal / vaginal interventions, except:
- Adhesiolysis
- Endometriosis removal (without rectovaginal endometriosis)
- Conization
- Hysteroscopy / curettage
- Immunosuppressive therapy with cytostatics, glucocorticoids, HIV
- Bleeding tendency / haemophilia
- Acute infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Arm A (test surgical technique)
Colpotomy closure technique: 3 Z-suture with PDS 0 and 1 continuous suture with V-Loc 2-0
|
Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0
|
|
ACTIVE_COMPARATOR: Arm B (control surgical technique)
Colpotomy closure technique: 3 Z-suture with PDS 0
|
Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with vaginal stump infection in intervention group and control group
Time Frame: 6 weeks
|
7.-10. day and 6 weeks postoperatively:
The diagnosis of vaginal stump infection was made based on 2 of 3 positive clinical symptoms, 1 additional criterion and the corresponding sonographic findings. I. Clinical symptoms: 1. Fever> = 38 ° C; 2. Dolence, redness, swelling, pus in the colpotomy area; 3. Lower abdominal pain ( VAS >5) II. Sonographic signs (TVUS): encapsulated cystic mass on the vaginal stump Additional criteria: 1. CRP increased (> 10mg / l); 2. Antibiotic therapy needs |
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify of patient-based and treatment-based risk factors for vaginal stump infection.
Time Frame: 6 weeks
|
connection between Obesity ( BMI >30 kg/ m2), nicotine abuse ( >5 cigarettes/d), anemia ( Hb <120g/L), operation time ( >120min), uterine volume ( >100 cm3) and appearance of vaginal stump infection
|
6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tatiana Naydina Ragaz, Tatiana Naydina Ragaz, Deputy Senior Gynecologist Women's Clinic, Spital Limmattal, Zurich Schlieren
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BASEC-Nr.2018-00777
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Infection
-
El-Galaa Military Medical ComplexCompletedVaginal Infection | Vaginal Cuff Dehiscence | Vaginal HematomaEgypt
-
Curatek Pharmaceuticals, LLCCompletedVaginal InfectionUnited States
-
Curatek Pharmaceuticals, LLCCompletedVaginal InfectionUnited States
-
Lumara Health, Inc.Completed
-
Carmel Medical CenterCommon Sense; Lin Medical Center, HaifaCompleted
-
Curatek Pharmaceuticals, LLCCompletedVaginal InfectionUnited States
-
Assiut UniversityUnknown
-
Chang Gung Memorial HospitalCompletedHuman Papillomavirus | Vaginal InfectionTaiwan
-
Alaa Nadhim HameedCompletedEpisiotomy Wound | Normal Vaginal Delivery | Episiotomy Infection | Surgical Site Infection PreventionIraq
Clinical Trials on Total laparoscopic hysterectomy
-
University of PalermoNot yet recruiting
-
Brigham and Women's HospitalWithdrawnGynecologic DiseasesUnited States
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...CompletedHysterectomyTurkey (Türkiye)
-
Antalya Training and Research HospitalCompleted
-
Queensland Centre for Gynaecological CancerNational Health and Medical Research Council, Australia; Johnson & Johnson... and other collaboratorsCompletedEndometrial CancerUnited Kingdom, Australia, Hong Kong, New Zealand
-
University of Texas Southwestern Medical CenterCompletedSurgery | Fibroid Uterus | Abnormal Uterine Bleeding | Uterine BleedingUnited States
-
Kafrelsheikh UniversityNot yet recruitingTotal Laparoscopic Hysterectomy With Myoma ScrewEgypt
-
Ain Shams UniversityRecruitingTotal Laparoscopic HysterectomyEgypt
-
Queensland Centre for Gynaecological CancerCompletedFemale Reproductive ProblemAustralia
-
University of AarhusAarhus University HospitalCompletedOutpatient Hysterectomy